Migdal Insurance & Financial Holdings’s Alexion Pharmaceuticals ALXN Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-370	Closed	-$42K	–	756
2020 Q3	$42K	Buy	+370	New	+$39.9K	﹤0.01%	578
2020 Q1	–	Sell	-1,531	Closed	-$166K	–	802
2019 Q4	$166K	Sell	1,531 -44	-3%	-$4.71K	﹤0.01%	444
2019 Q3	$154K	Buy	1,575 +272	+21%	+$30.7K	﹤0.01%	504
2019 Q2	$171K	Buy	+1,303	New	+$168K	﹤0.01%	493
2018 Q4	–	Sell	-1,590	Closed	-$221K	–	830
2018 Q3	$221K	Buy	1,590 +942	+145%	+$118K	﹤0.01%	507
2018 Q2	$80K	Buy	648 +628	+3,140%	+$73.4K	﹤0.01%	542
2018 Q1	$2K	Buy	+20	New	+$2.39K	﹤0.01%	623

Other funds holding ALXN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Migdal Insurance & Financial Holdings's ALXN Position: Q4 2020 in Review

Migdal Insurance & Financial Holdings sold out of Alexion Pharmaceuticals (ALXN) in Q4 2020, closing a stake of 370 shares — an estimated $42K sold.

Migdal Insurance & Financial Holdings first reported a position in ALXN in Q1 2018 and held it in 7 quarters. The position peaked at $221K in Q3 2018. 825 funds tracked by Wall St. Rank hold ALXN as of Q4 2020.

Migdal Insurance & Financial Holdings reported no remaining Alexion Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
Migdal Insurance & Financial Holdings sold 370 Alexion Pharmaceuticals shares in Q4 2020, an estimated $42K.
Migdal Insurance & Financial Holdings first reported a position in Alexion Pharmaceuticals in Q1 2018 and held it in 7 quarters.
Migdal Insurance & Financial Holdings's Alexion Pharmaceuticals position peaked at $221K in Q3 2018.
825 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2020.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q4 2020, filed 8 Feb 2021.